Skip to main content
. 2017 Jun 20;32(3):e22283. doi: 10.1002/jcla.22283

Table 1.

Demographic characteristics of two study groups

Control group Diabetic group P
N (male/female) 119 (34/85) 180 (90/90) <.001
Age, years 55.00 (36.25‐66.75) 63.00 (55.00‐69.00) <.001
BMI, kg/m2 26.96 (23.26‐30.46) 29.07 (26.80‐32.28) .003
WC, cm 96.00 (86.00‐104.75) 106.00 (98.50‐146.00) <.001
SBP, mmHg 133.00 (127.00‐141.75) 134.00 (126.00‐142.00) .801
DBP, mmHg 77.00 (70.00‐80.00) 80.00 (70.00‐85.00) .102
Smoking habits, (Smoker/Non‐smoker) 28/91 42/138 .969
Hypolipemics (Yes/No) 23/96 77/103 <.001
Statins (Controls/Diabetics, 23/77)
Fibrates (Controls/Diabetics, 0/6)
Antihypertensives (Yes/No) 58/61 129/51 <.001
ACE inhibitors (Controls/Diabetics, 51/116)
Beta blockers (Controls/Diabetics, 36/31)
Diuretics (Controls/Diabetics, 19/68)
Antihyperglycemics (Yes/No) 0/157 <.001
Metformin (Controls/Diabetics, 0/149)
Sulfonylurea (Controls/Diabetics, 0/8)
Insulin (Controls/Diabetics, 0/31) 0/31
Duration of diabetes, years 4.00 (2.00‐9.00)

Data are presented as median (interquartile range) and compared by Mann‐Whitney test.

Categorical variables are presented as absolute frequencies and compared by Chi‐square test.